Nobody had more to lose from the suspension of the Ant float than the bookrunners, in particular the joint sponsors. They had closed books on a record deal that looked good not just for them and Ant but for the Greater China capital markets. There are many questions about what happens next: how should Ant be reshaped to revive the listing and who should share the blame for not responding to shifting regulatory sands?